Fox Run Management’s Adaptive Biotechnologies ADPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $235K | Sell |
20,195
-1,370
| -6% | -$16K | 0.04% | 712 |
|
2025
Q1 | $160K | Buy |
21,565
+1,631
| +8% | +$12.1K | 0.02% | 822 |
|
2024
Q4 | $120K | Buy |
+19,934
| New | +$120K | 0.02% | 795 |
|
2023
Q3 | – | Sell |
-21,724
| Closed | -$146K | – | 674 |
|
2023
Q2 | $146K | Buy |
21,724
+1,375
| +7% | +$9.23K | 0.04% | 616 |
|
2023
Q1 | $180K | Buy |
20,349
+1,124
| +6% | +$9.93K | 0.06% | 552 |
|
2022
Q4 | $147K | Buy |
+19,225
| New | +$147K | 0.06% | 528 |
|
2022
Q2 | – | Sell |
-14,491
| Closed | -$201K | – | 498 |
|
2022
Q1 | $201K | Buy |
+14,491
| New | +$201K | 0.11% | 416 |
|
2021
Q4 | – | Sell |
-8,912
| Closed | -$303K | – | 449 |
|
2021
Q3 | $303K | Buy |
+8,912
| New | +$303K | 0.19% | 226 |
|